HSBC Holdings’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$550K Buy
23,254
+5,971
+35% +$123K ﹤0.01% 2234
2026
Q1
$301K Buy
17,283
+1,869
+12% +$38.5K ﹤0.01% 2452
2025
Q4
$365K Sell
15,414
-464
-3% -$12K ﹤0.01% 2436
2025
Q3
$497K Buy
15,878
+2,485
+19% +$75K ﹤0.01% 2107
2025
Q2
$382K Buy
+13,393
New +$402K ﹤0.01% 2303

Other funds holding SMTI

HSBC Holdings's SMTI Position: Q2 2026 in Review

HSBC Holdings increased its Sanara MedTech (SMTI) stake by 35% in Q2 2026, buying an estimated $123K and bringing the position to 23,254 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #2234.

HSBC Holdings first reported a position in SMTI in Q2 2025 and has held it in 5 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • HSBC Holdings held 23,254 shares of Sanara MedTech worth $550K as of Q2 2026.
  • HSBC Holdings bought 5,971 Sanara MedTech shares in Q2 2026, an estimated $123K.
  • Sanara MedTech made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2234 holding.
  • HSBC Holdings first reported a position in Sanara MedTech in Q2 2025 and has held it in 5 quarters since.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.